Literature DB >> 20846160

Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

S I Mannering1, F S Wong, I Durinovic-Belló, B Brooks-Worrell, T I Tree, C M Cilio, N C Schloot, R Mallone.   

Abstract

Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846160      PMCID: PMC2996587          DOI: 10.1111/j.1365-2249.2010.04237.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  60 in total

Review 1.  Measurement of CD8 T cell responses in human type 1 diabetes.

Authors:  Emanuela Martinuzzi; François A Lemonnier; Christian Boitard; Roberto Mallone
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 2.  Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.

Authors:  Bart O Roep; Mark Peakman
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

3.  Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.

Authors:  M Peakman; T I Tree; J Endl; P van Endert; M A Atkinson; B O Roep
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Authors:  Gabrielle G M Pinkse; Odette H M Tysma; Cees A M Bergen; Michel G D Kester; Ferry Ossendorp; Peter A van Veelen; Bart Keymeulen; Danny Pipeleers; Jan W Drijfhout; Bart O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

6.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.

Authors:  Amit Goel; Harvey Chiu; Jamie Felton; Jerry P Palmer; Barbara Brooks-Worrell
Journal:  Diabetes       Date:  2007-05-01       Impact factor: 9.461

8.  Human T-cells recognise N-terminally Fmoc-modified peptide.

Authors:  Stuart I Mannering; Anthony W Purcell; Margo C Honeyman; James McCluskey; Leonard C Harrison
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

9.  Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.

Authors:  P Santamaria; T Utsugi; B J Park; N Averill; S Kawazu; J W Yoon
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

10.  Visualizing antigen specific CD4+ T cells using MHC class II tetramers.

Authors:  Eddie A James; Rebecca LaFond; Ivana Durinovic-Bello; William Kwok
Journal:  J Vis Exp       Date:  2009-03-06       Impact factor: 1.355

View more
  22 in total

Review 1.  The case for an autoimmune aetiology of type 1 diabetes.

Authors:  S I Mannering; V Pathiraja; T W H Kay
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

Review 2.  Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature.

Authors:  Slobodan Culina; Roberto Mallone
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

3.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 4.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes.

Authors:  Jennie H M Yang; Kirsten A Ward-Hartstonge; Daniel J Perry; J Lori Blanchfield; Amanda L Posgai; Alice E Wiedeman; Kirsten Diggins; Adeeb Rahman; Timothy I M Tree; Todd M Brusko; Megan K Levings; Eddie A James; Sally C Kent; Cate Speake; Dirk Homann; S Alice Long
Journal:  Eur J Immunol       Date:  2022-01-28       Impact factor: 5.532

Review 6.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

7.  Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.

Authors:  Michelle So; Colleen M Elso; Eleonora Tresoldi; Miha Pakusch; Vimukthi Pathiraja; John M Wentworth; Leonard C Harrison; Balasubramanian Krishnamurthy; Helen E Thomas; Christine Rodda; Fergus J Cameron; Jacinta McMahon; Thomas W H Kay; Stuart I Mannering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

8.  Extraction of tissue antigens for functional assays.

Authors:  Andra Necula; Rochna Chand; Batool Albatat; Stuart I Mannering
Journal:  J Vis Exp       Date:  2012-09-10       Impact factor: 1.355

Review 9.  Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.

Authors:  Kriti Joshi; Fergus Cameron; Swasti Tiwari; Stuart I Mannering; Andrew G Elefanty; Edouard G Stanley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

10.  Diagnostic value of combined islet antigen-reactive T cells and autoantibodies assays for type 1 diabetes mellitus.

Authors:  Wei Tang; Huiying Liang; Ying Cheng; Jiao Yuan; Gan Huang; Zhiguang Zhou; Lin Yang
Journal:  J Diabetes Investig       Date:  2020-11-27       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.